James R. Kasinger

General Counsel and Secretary

James R. Kasinger (General Counsel and Secretary) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in CRISPR Therapeutics AG (CRSP). The largest single filing was $166K of CRSP (3,450 sh × $48.26, as filed), executed Mar 16.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$574K

shares × price, as filed

Last traded

Mar 23

Filed Mar 24

Median ADV $94.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $1.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

CRSP

CRISPR Therapeutics AG CRSP · 0 buys · 7 sells 7 filings

Recent filings

CRSPSALE CRISPR Therapeutics AG View filing → $149K
3,182 sh × $46.78
Exec Mar 23
Filed Mar 24 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $166K
3,450 sh × $48.26
Exec Mar 16
Filed Mar 17 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $148K
2,800 sh × $52.80
Exec Mar 11
Filed Mar 12 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $111K
2,112 sh × $52.58
Exec Feb 19
Filed Feb 20 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $131K
3,185 sh × $41.23
Exec Mar 21 2025
Filed Mar 24 2025 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $121K
2,850 sh × $42.42
Exec Mar 11 2025
Filed Mar 12 2025 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $619K
11,542 sh across 2 lots
Exec Feb 18 2025
Filed Feb 19 2025 · 5:30 PM ET